Cerecin's Debt - II Round

Cerecin raised a round of funding on May 24, 2012. Investors include Inventages Venture Capital.

Cerecin, fka Accera, is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative …

Articles about Cerecin's Debt - II Round: